| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9902 | 
      | Human Intestinal Absorption | HIA+ | 0.7791 | 
      | Caco-2 Permeability | Caco2- | 0.7361 | 
      | P-glycoprotein Substrate | Substrate | 0.6431 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8785 | 
                                                     | Non-inhibitor | 0.5144 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9001 | 
        
            | Distribution | 
        
      | Subcellular localization | Plasma membrane | 0.3317 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8607 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8249 | 
      | CYP450 3A4 Substrate | Substrate | 0.5194 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7883 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8015 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8968 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7618 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8547 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9447 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9925 | 
                                                                    | Non-inhibitor | 0.9063 | 
      | AMES Toxicity | Non AMES toxic | 0.7914 | 
      | Carcinogens | Non-carcinogens | 0.8518 | 
      | Fish Toxicity | High FHMT | 0.9388 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9326 | 
      | Honey Bee Toxicity | Low HBT | 0.6102 | 
      | Biodegradation | Not ready biodegradable | 0.9907 | 
      | Acute Oral Toxicity | IV | 0.4734 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5327 |